Amgen to lay off 226 in Thousand Oaks
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”19-04-2011″ enddate=”19-10-2011″ width=”300″ height=”245″] Thousand Oaks-based Amgen is laying off 226 people at its headquarters as part of a restructuring of its research operations. Worldwide, the R&D shakeup will affect 380 staff members, but the company’s headquarters are bearing the brunt of the cuts. The company said the layoffs are Read More →
Ryland calls the movers: Homebuilder plants headquarters in Westlake Village
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Santa Barbara software fishes for high-frequency trades
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Power-One docks outlook on Eurozone austerity
Power products company Power-One slashed its third-quarter outlook Oct. 11, causing stocks to sink 3.8 percent in after-hours trading. The Camarillo-based firm cut its outlook for third-quarter sales to the $240 million to $245 million range, down from its previous outlook of $265 million to $280 million. It said power conversion revenue was down about Read More →
Dole buys blueberry business
Dole Food Co. has purchased a Florida blueberry company, it said Oct. 11. Westlake Village-based Dole, the largest producer of organic bananas in the world and of the biggest players in the fresh fruit and vegetable industry, said it had acquired all of the capital stock of the parent of SunnyRidge Farm. Terms of the Read More →
Vitesse slashes work force, faces lawsuit
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen braces for biosimilars rules
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
